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Background: Autoimmune reactions and subsequent inflammation may underlie spermatogenic dysfunction 56 
and endometriosis-related infertility. The aim of this study is to identify disease-specific antigens in immune 57 
complexes (ICs) in seminal plasma (SP) and in follicular fluid (FF). 58 
Methods: Immune complexome analysis, in which nano-liquid chromatography-tandem mass spectrometry is 59 
employed to comprehensively identify antigens incorporated into ICs in biological fluids, was performed for 60 
specimens collected from infertile couples undergoing assisted reproduction. Forty-two male patients 61 
consisting of subjects with oligozoospermia (n=6), asthenozoospermia (n=8), and normal semen analysis 62 
(n=28). Fifty-eight female patients consisting of subjects with ovarian endometriosis (n=10) and control 63 
women without disease (n=48). 64 
Results: Four disease-specific antigens were identified in subjects with oligozoospermia, while five 65 
disease-specific antigens were detected in subjects with asthenozoospermia, some of which are involved in 66 
sprematogenesis. Eight antigens were detected only in subjects with endometriosis. 67 
Conclusion: Functional characteristics of disease-specific antigens were found to correspond to the 68 
pathogenesis of male and female infertility. The formation of ICs may contribute to spermatogenic 69 
dysfunction and endometriosis-related infertility via loss of function of the related proteins. Immune 70 
complexome analysis is expected to be a valuable tool for the investigation of novel diagnostic methods and 71 




1. Introduction 74 
Local immunity may play an important role in human reproduction, and disorders in local immunity can 75 
be the cause of male and female infertility [1, 2].  76 
Spermatogenic dysfunction is a major cause of male infertility, though its pathogenesis is not fully 77 
understood. Inflammation in the male reproductive tract may disrupt spermatogenesis and sperm function. 78 
Destruction of testicular microstructures can induce immunity against sperm [3]. Although autoimmune 79 
orchitis and epididymitis may be rare occurrences, these conditions may relate to immunological male 80 
infertility [4]. However, even subclinical inflammation and local autoimmune reaction in the male 81 
reproductive tract can be a cause of male infertility. To permit normal spermatogenesis and fertility, the 82 
mammalian testis is maintained as an immune-privileged organ wherein immunogenic germ cells are 83 
protected from immune surveillance [1]. The Sertoli cell barrier, also known as the blood–testis barrier (BTB), 84 
plays an important role in the construction of this unique microenvironment [5]. When the BTB is impaired 85 
due to infection, injury, or obstruction of genital ducts, a large amount of sperm antigen is exposed to immune 86 
cells by leakage or infiltration, leading to sperm immunity [6]. Inflammation of the testis may affect male 87 
reproductive function. Subacute and chronic inflammation of the testis and epididymis are asymptomatic in 88 
the most patients, and there are no reliable clinical diagnostic measures [3]. As a local body fluid of the male 89 
reproductive tract, seminal plasma (SP), mediates male fertility by supporting sperm metabolism, modulating 90 
sperm function, and protecting sperm against the damage induced by the immune system via suppression of 91 
immune activity [7, 8]. SP, which is formed by secretion from male reproductive organs including the 92 
epididymis, seminal vesicles, prostate gland, and Cowper’s gland, contains many kinds of tissue-specific 93 
proteins, reflecting the afore-mentioned specific characteristics of male reproductive organs. Most of these 94 
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tissue-specific proteins are intracellular proteins, including those associated with the membrane, cytoplasm, 95 
and nucleus [9-11]. The high concentration of intracellular proteins in SP may reflect the fact that most body 96 
cells interact with plasma and release components into the plasma during cell damage or death. [12]. As a 97 
result, these tissue- and cell-specific proteins are abundant in SP compared to serum or urine. Although only 98 
10% of the protein components of SP originate from testis or epididymis, these proteins play an important role 99 
in sperm quality, are associated with testicular function, and have been implicated in male reproductive 100 
disorders [8-11, 13]. Thus, changes in composition of the SP proteome may reflect a pathological process in 101 
male reproductive disorders [9]. 102 
Endometriosis is a chronic pelvic inflammatory disease and one of the major causes of female infertility. 103 
Endometriosis is characterized by the presence of ectopic endometrial tissue outside of the uterine cavity, and 104 
is manifested by chronic local inflammation in the pelvis. As with spermatogenic dysfunction, the 105 
pathogenesis of endometriosis is enigmatic. However, local immunity in the female pelvis also may be 106 
involved in the pathogenesis of endometriosis-related infertility. The mechanisms of endometriosis-related 107 
infertility vary, and include peritoneal adhesion, dysfunctional uterotubal motility, disturbed folliculogensis, 108 
and detrimental effects on spermatozoa [14, 15]. Ovarian endometriotic lesions (endometriomas) are one of 109 
the main disease phenotypes, and local inflammatory reactions surrounding endometriomas may affect 110 
folliculogenesis and the process of oocyte maturation [14]. In fact, the ovary affected by endometriomas may 111 
show fibrosis and altered folliculogenesis, effects that may result from local chronic inflammation [16, 17]. 112 
These findings imply that the local follicular milieu may be disturbed by endometriosis. On the other hand, 113 
several studies have reported a relationship between endometriosis and autoimmune disease [18, 19]. In these 114 
reports, endometriosis shows symptoms similar to those of autoimmune disease. In addition, various 115 
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auto-antibodies are produced in subjects with endometriosis [20]. The contents of follicular fluid (FF) are 116 
formed by osmotic pressure gradient generated by hyaluronan and versican recruits blood exudate into the 117 
follicle. Antibodies can pass through the ovarian blood-follicle barriers and diffuse into FF [21, 22]. Moreover, 118 
cytokines, reactive oxygen species, and antioxidants produced by inflammation may be elevated in the FF of 119 
subjects with endometriosis [23]. Due to these facts, the FF generated by subjects with endometriosis may in 120 
turn affect the growth of endometriomas [24]. 121 
As mentioned above, autoimmune reactions and subsequent inflammation may underlie spermatogenic 122 
dysfunction and endometriosis-related infertility. However, while SP and FF are local body fluids of the 123 
gonads and reproductive tract, it is unknown what component(s) of SP and FF are recognized as auto-antigens, 124 
thereby triggering inflammation in the corresponding tissues. Immune complexes (ICs) are formed by 125 
noncovalent interactions between foreign antigens or autoantigens and antibody molecules [25]. Enhanced 126 
formation and defective clearance of ICs occurs in autoimmune diseases [26]. In order to comprehensively 127 
identify and profile constituent antigens in ICs, we developed a proteomic strategy, designated immune 128 
complexome analysis, in which ICs are separated from whole serum and then subjected to direct tryptic 129 
digestion and nano-liquid chromatography-tandem mass spectrometry [27]. We have successfully used this 130 
method to identify specific antigens in circulating ICs (CIC-antigens) in serum or cerebrospinal fluid 131 
recovered from subjects with autoimmune diseases, infectious diseases, and cancers, as well as those who are 132 
liver transplant recipients [27-31]. 133 
In the present study, we applied immune complexome analysis to SP and FF collected from infertile 134 
couples undergoing assisted reproduction. The goal of this analysis was to comprehensively identify 135 
IC-antigens, with the intent of identifying those IC-antigens specific for infertile males and for infertile 136 
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women with endometriosis. Formation of ICs between the specific antigens and their corresponding 137 
autoantibodies might affect the physiological functions of the antigens, possibly leading to male and female 138 
infertility. Additionally, IC formation and deposition on tissues is known to stimulate inflammatory processes 139 
via the action of the complement system. It is hoped that the present study may lead to elucidation of the 140 
pathogenesis of male infertility and endometriosis involving immune abnormality, and to the development of 141 
new therapies to treat these fertility challenges. 142 
 143 
2. Materials and Methods 144 
2.1. Patients 145 
All samples were collected from infertile couples undergoing assisted reproduction technology (ART) at 146 
Nagasaki University Hospital; written consent was obtained from all participating patients. Infertility is 147 
defined as the couple who suffer from the failure to achieve a clinical pregnancy after 12 months or more of 148 
regular unprotected sexual intercourse. Before ART, male subjects received semen analysis and female 149 
subjects received the test for tubal patency by hysterosalpingography or laparoscopy, ovarian function by 150 
hormonal analysis and serial transvaginal ultrasonography, pelvic pathology, such as uterine and ovarian 151 
tumors, by ultrasonography and/or MRI. The couples with azoospermia or primary ovarian insufficiency were 152 
excluded. This study was performed according to Helsinki Declaration and was approved by the Nagasaki 153 
University Hospital Ethics Committee (Research Ethics Committee Approval No. 16020804). 154 
 155 
2.2. SP 156 
Forty-two semen samples were collected. After complete liquefaction, an aliquot of the ejaculate was 157 
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employed for semen analysis using a Makler counting chamber (Irvine Scientific, Santa Ana, CA). Semen 158 
volume (mL), sperm concentration (106/mL), and motility (%) were recorded and classified according to the 159 
WHO guidelines [32]. Subjects were divided into three groups: the oligozoospermia group (n=6), which 160 
consisted of male subjects with sperm concentrations lower than 15×106/mL without regard for sperm 161 
motility; the asthenozoospermia group (n=8), which consisted of male subjects with sperm motility less than 162 
40% but with normal sperm concentrations (>15 ×106/mL); and the normal control group (n=28), which 163 
consisted of males for whom both sperm concentration and motility exceeded the lower reference limits of the 164 
WHO criteria (>15 ×106/mL, >40%). After semen analysis, the remaining semen was washed using Sperm 165 
Washing Medium® (Irvine Scientific) and then was centrifuged at 2.0 × 104 x g for 10 min to separate the 166 
pellet and supernatant. The resulting supernatant was frozen at -40 °C; an aliquot (10 μL) was used for the 167 
immune complexome analysis. In this study, SP samples were derived from not only men with definitive male 168 
factor infertility but also the couple with female factor infertility. In oligozoospemia group, all couple were 169 
primary infertility and there were no female partners with infertility factors. In asthenozoospermia group, six 170 
subjects were primary infertility and two subjects were secondary infertility, and there were three couples with 171 
female factor infertility, such as endometriosis (n=2) and ovulatory dysfunction (n=1). In normal control 172 
group, 24 subjects were primary infertility and four subjects were secondary infertility, and there were 15 173 
couples with female factor infertility, such as tubal factor (n=6), ovulatory dysfunction (n=5), endometriosis 174 
(n=3), and woman with anti-centromere antibody (n=1). 175 
 176 
2.3. FF 177 
Fifty-eight samples were collected; the subjects were divided into two groups. The endometriosis group 178 
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consisted of 10 women who had been diagnosed as having one or more endometriomas at a previous operation. 179 
At the time of surgery, cystectomy was performed in six subjects, drainage and cystic wall ablation were 180 
performed in three subjects and hemilateral cystectomy and contralateral ablation were performed in one 181 
woman with bilateral lesions. The average period from surgery to oocyte retrieval was 2.8 ± 4.1 years (mean ± 182 
 standard deviation). The other women lacked subjective and objective clinical symptoms of endometriosis 183 
and were designated as a control group (n=48). Although all subjects received pelvic examination and 184 
transvaginal ultrasonography before ART to rule out the pelvic pathology, 15 (31%) of them had been 185 
undergone pelvic surgery for indications other than endometriosis, and they were confirmed not to have the 186 
disease. At the time of transvaginal oocyte retrieval, FF was collected from the first punctured follicle. After 187 
transferring the egg to the culture medium, FF was centrifuged at 2.8 × 104 x g for 5 min and an aliquot (10 188 
μL) of the supernatant was used for immune complexome analysis.  189 
 190 
3. Experimental 191 
3.1. Immune complexome analysis 192 
ICs in SP or FF were collected using ProceptorTM-sepharose beads. An aliquot (40 μL) of each bead 193 
type was incubated with 10 μL of pooled human serum diluted with 90 μL phosphate-buffered saline (PBS) 194 
for 30 min with gentle mixing. The beads were pelleted by 1 min of centrifugation and the supernatant was 195 
removed with a pipette. The beads were washed three times with 500 μL PBS/wash. Washed beads were 196 
suspended in 50 μL of 10 μg/mL papain solution (0.04 M EDTA, 0.04 M L-cysteine) and incubated at 37 °C 197 
for 30 min. Then, 50 μL of 0.06 M iodoacetamide dissolved in PBS was added to quench the papain digestion. 198 
Next, we added 100 μL of 10 mM dithiothreitol and further incubated the sample at 56 °C for 45 min. Then, 199 
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100 μL of 55 mM iodoacetamide was added, and the mixture was incubated in the dark at room temperature 200 
for another 30 min. Trypsin in 0.05% acetic acid was added to yield a final concentration of 0.5 g of trypsin/L, 201 
and the mixture was incubated overnight at 37 °C. An aliquot (12 µL) of 10% TFA in water was added to the 202 
mixture to quench the digestion. The beads were pelleted by 1 min of centrifugation; the resulting supernatant 203 
(approximately 400 µL) was recovered, vacuum-reduced to a volume of approximately 80 µL, and stored at 204 
4 °C pending subsequent analysis by nano-LC-MS/MS. The peptide mixture (1 μL) was injected into an 205 
LC–electrospray ionization (ESI)–MS/MS instrument (Q-Exactive, Thermo Fisher Scientific, Waltham, MA, 206 
USA) was equipped with EASY-nLCTM 1200 system consisting of a nano LC pump) and an autosampler was 207 
used for anlaysis. Peptides were deionized and were concentrated on pre-column (Acclaim PepMapTM 100, 75 208 
µm x 2 cm, nano Viper, C18, 3 µm, 100 Å, Thermo Fisher Scientific), and were subsequently separated on a 209 
nano-LC column (C18, 75 µm i.d. x 125 mm, 3 µM particle, 100 Å pore size, Nikkyo Technos, Tokyo, Japan) 210 
and ion-sprayed into MS with a spray voltage of 1.5 kV. The separation was performed by using the mobile 211 
phase A (0.1% formic acid) and mobile phase B (0.1% formic acid in 90% acetonitrile), employing a gradient 212 
elution from 5% to 33% mobile phase B in 100 min, and 100% mobile phase B held for 10 min. MS/MS data 213 
were extracted using Proteome Discoverer 1.3.1.339 (Thermo Fisher Scientific). Spectra were searched 214 
against sub-databases from the public nonredundant protein database of UniProt Knowledgebase (human, 215 
2015.01.29 download) with the following search parameters: mass type, monoisotopic precursor and 216 
fragments; enzyme, trypsin (KR); enzyme limits, full enzymatic cleavage allowing up to two missed 217 
cleavages; peptide tolerance, 10 ppm; fragment ion tolerance, 0.8 Da; ion and ion series calculated, B and Y 218 
ions; static modification, C (carbamidomethylation); and differential modifications, M (oxidation), N, and Q 219 
(deamidation). All the results were obtained by triplicate analyses. All the peptides and proteins found in the 220 
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first, second and/or third analysis were counted in the numbers of identified peptides and proteins. The 221 
procedure has been described in detail in our previous publication [33]. 222 
 223 
3.2. Statistical analysis 224 
Statistical analysis was performed using Stat Mate V software (ATMS, Tokyo, Japan); the significance 225 
level was defined as a p value <0.05. An F test was used to test the normality of distributions. Continuous 226 
variables that exhibited skewed distributions by the F test were analyzed using a two-tailed Kruskal-Wallis H 227 
test with post-hoc Dunnett’s test. Continuous variables that exhibited normal distributions by the F test were 228 
analyzed using a two-tailed one-way analysis of variance (ANOVA) with post-hoc Tukey-Kramer test. For 229 
female patients, age, serum anti-Müllerian hormone (AMH), and the number of retrieved oocytes were 230 
analyzed using a Mann-Whitney U-test. Fisher’s exact test for parity was used for comparisons between two 231 
groups. 232 
 233 
4. Results 234 
4.1.1 Clinical backgrounds of the male subjects provided seminal plasma 235 
Age and the results of semen analysis in the male subjects are summarized in Table 1. There was no 236 
statistically significant difference in age or semen volume among the three groups. Consistent with the 237 
group-assignment criteria, sperm concentrations in the oligozoospermia group were significantly lower than 238 
those in the other groups (p < 0.05 versus asthenozoospermia, p < 0.001 versus normal semen analysis). 239 
Similarly, there was a statistically significant difference in sperm motility, between the asthenozoospermia 240 
group and the normal group (p < 0.001). We also detected a significant difference in sperm motility between 241 
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the oligozoospermia and normal groups (p < 0.01). 242 
4.1.2 Clinical backgrounds of the female subjects provided follicular fluid 243 
Table 2 shows the clinical backgrounds of the female subjects, including: age, serum AMH levels, the 244 
number of retrieved oocytes, the number of subjects with nulligravida, the number of subjects with nullipara, 245 
the stage of endometriosis according to the revised American Society for Reproductive Medicine system, the 246 
number of subjects from whom FF was collected from the affected side, and the number of subjects with 247 
recurrent cyst(s) at the time of oocyte retrieval [34]. There were no statistically significant differences between 248 
the two groups for any of these variables. 249 
4.2. Immune complexome analysis 250 
4.2.1. SP 251 
Here, we present for the first time (to our knowledge) a comprehensive identification of the 252 
constituent antigens assembled into CICs in SP from male infertility patients with spermatogenesis 253 
dysfunction (oligozoospermia or asthenozoospermia), or into CICs in FF from female infertility patients with 254 
ovarian endometriosis. Among the studied subjects, we identified 391 and 327 human antigens in SP of male 255 
subjects and FF of female subjects (respectively) via immune complexome analysis. 256 
While the majority of antigens detected in SP were observed in both SP derived from patients with 257 
spermatogenesis dysfunction (oligo- and astheno-zoospermia) and SP derived from normal controls, four 258 
antigens were found only in SP derived from subjects with oligozoospermia; these antigens were not detected 259 
in SP from the other two groups (Table 3). Among the four disease-specific antigens identified in SP of 260 
oligozoospermia, sperm protein associated with the nucleus on the X chromosome D (also known as 261 
SPANX-D) was found in three of six oligozoospermia subjects (50%). The other three 262 
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oligozoospermia-specific antigens included zyxin, fasciculation and elongation protein zeta-2, and a probable 263 
asparagine-tRNA ligase; these three antigens were found in two of six subjects, without a specific pattern. SP 264 
from two subjects exhibited three of these oligozoospermia-specific antigens; SP from one subject retained 265 
two of these antigens; SP from one subject retained one of these antigens; and SP from two subjects did not 266 
retain any of these antigens. There was no specific pattern regarding the number of antigens present per 267 
subject, nor did the presence of various antigens appear to relate to the severity of oligozoospemia (data not 268 
shown). 269 
Five asthenozoospermia-specific antigens (dual specificity testis-specific protein kinase 2 (also 270 
known as TESK2), probable E3 ubiquitin-protein ligase HERC1, uncharacterized protein KIAA1109, protein 271 
arginine N-methyltransferase 7, and ATP-binding cassette sub-family F member 1) were detected in in SP 272 
from six of eight subjects with asthenozoospermia; these antigens were not detected in SP from the other two 273 
groups (Table 4). Each antigen was detected at a frequency of 25% within subjects with asthenozoospermia 274 
without a specific pattern. SP from two subjects retained three disease-specific antigens; SP from four patients 275 
retained one specific antigen; and SP from two patients did not retain any of these specific antigens. There was 276 
no specific pattern regarding the number of antigens present per subject, nor did the presence of various 277 
antigens appear to relate to the severity of asthenozoospermia (data not shown).  278 
 279 
4.2.2. FF 280 
Although the majority of 327 antigens identified in FF were present both in FF from subjects with 281 
endometriosis and in FF from those without endometriosis, eight antigens were detected only in the 282 
endometriosis group; these eight antigens were not detected in FF from the control group (Table 5). These 283 
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specific antigens (fibroblast growth factor receptor 1 (also known as FGFR1), probable ubiquitin 284 
carboxyl-terminal hydrolase FAF-Y (also known as Deubiquitinating enzyme FAF-Y), interleukin-6 receptor 285 
subunit beta (also known as gp130), sentrin-specific protease 1, centlein, Neuralized-like protein 4, 286 
apolipoprotein B receptor, and WSC domain-containing protein 1) in FF were detected in six of ten subjects. 287 
Each antigen was detected at a frequency of 20% among subjects with endometriosis; no specific pattern was 288 
observed. FF from one subject each retained five specific antigens, four specific antigens, and three specific 289 
antigens; FF from three subjects retained one of these antigens, while those from the remaining four subjects 290 
did not harbor any of these specific antigens. There was no specific pattern regarding the number of antigens 291 
present per subject, nor did the presence of various antigens appear to relate to the severity of endometriosis 292 
(data not shown). 293 
 294 
5. Discussion 295 
In this study, we demonstrated for the first time (to our knowledge) that disease-specific ICs are formed 296 
in the local body fluids of the reproductive tracts, such as SP and FF, obtained from infertile males and 297 
females, when assessed by proteomic immune complexome analysis. ICs are formed by the binding of 298 
immunoglobulins to self and non-self antigens to promptly recognize autoantigens or prevent the spread of 299 
non-self antigens. When excessive numbers of ICs are produced, the complexes may induce inflammation and 300 
tissue damage via activation of complement. In addition, the deposition of ICs in tissues can cause fibrosis, 301 
atrophy, and dysfunction due to type-III hypersensitivity, endothelial dysfunction, and tissue remodeling [35]. 302 
Moreover, IC-associated antigens (proteins) may lose their function due to IC formation. Thus, comprehensive 303 
analysis of ICs and their antigens may facilitate the definition of the pathogenesis of disorders relevant to 304 
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immune responses and inflammation. 305 
In this study, we demonstrated for the first time (to our knowledge) that disease-specific ICs are formed 306 
in the local body fluids of the reproductive tracts, such as SP and FF, obtained from infertile males with 307 
spermatogenesis dysfunction and females with endometriosis, when assessed by proteomic immune 308 
complexome analysis. Immune response and inflammation in the local environment may be involved in the 309 
pathogenesis of both disorders. To our knowledge, most of the disease-specific antigens identified in this 310 
study had not previously been reported to be associated with the respective disease; nonetheless, some of these 311 
antigens may correspond to the disease pathology. The specific antigens detected in SP may function as 312 
components of BTB, DNA repair machinery, or sperm nuclear envelopes. In contrast, the proteins specifically 313 
detected in FF are known to be related to inflammation. Interestingly, none of the detected IC-antigens were 314 
shared among the oligozoospermia, asthenozoospermia, and endometriosis groups. These results may reflect 315 
the specific role of ICs in each disorder, implying that the analysis of ICs may contribute to expanding our 316 
knowledge of specific diseases. 317 
Several papers have suggested an association between spermatogenic dysfunction and autoimmune 318 
response against sperm [1, 3, 5, 6]. For instance, the BTB is formed by Sertoli cells in the seminiferous 319 
epithelium and plays an important role in maintaining a microenvironment (notably, an immunoprivileged 320 
compartment) that is suitable for spermatogenesis [1]. However, the BTB can be disrupted by inflammation; 321 
therefore, identification of specific BTB autoantigens may be crucial for understanding the pathological 322 
processes of BTB disruption [36]. In this context, among the nine disease-specific antigens identified in the SP 323 
of the oligozoospermia and asthenozoospermia groups, zyxin and TESK2 are known components of the BTB 324 
[37, 38]. Production of antibodies against these proteins, as suggested by the presence of corresponding ICs in 325 
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the present study, may lead to antigen-specific inflammation and BTB disruption. 326 
SPANX-D, which was detected in half of SP specimens derived from oligozoospermia subjects, and the 327 
probable E3 ubiquitin-protein ligase HERC1 (HECT-type E3 ubiquitin transferase HERC1), which was 328 
specifically detected in the asthenozoospermia group, are proteins involved in DNA damage repair [39-41]. IC 329 
formation may result in disorganized sperm production due to accumulation of DNA damage and genome 330 
instability by loss of the functions of these proteins. 331 
Among the eight specific antigens found in FF of subjects with endometriosis, several proteins might be 332 
involved in the pathogenesis of endometriosis, such as gp130, Deubiquitinating enzyme FAF-Y, and FGFR1. 333 
These proteins are known to regulate local inflammation, inflammasome formation, or the 334 
epithelial-to-mesenchymal transition (EMT) [42-45]. FF may be involved in the growth and maintenance of 335 
superficial ovarian endometriomas and peritoneal lesions [24]. Loss of function of specific antigens (which 336 
would result from excess formation of ICs) may render the local pelvic micro-environment favorable to the 337 
progression of endometriosis. IL-6 is a pro-inflammatory cytokine and may be involved in 338 
endometriosis-associated infertility [46]. The formation of ICs that include the IL-6R subunit beta (also 339 
known as gp130), which inhibits the pro-inflammatory trans-signaling cascade of IL-6 by binding to the 340 
complex formed by IL-6 and sIL-6R [42, 47], might lead to activation of trans-signaling and exacerbation of 341 
inflammation. 342 
On the other hand, altered folliculogenesis caused by destruction of normal ovarian cortical structures 343 
may be one of the causes of endometriosis-related infertility. Fibrotic changes in the ovarian cortex are 344 
associated with decreased follicular density and enhanced follicular recruitment and atresia [17, 18]. 345 
Dysregulation of the inflammasome and EMT caused by the formation of ICs including Deubiquitinating 346 
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enzyme FAF-Y and FGFR1, respectively, may be associated with exacerbation of inflammation and fibrosis 347 
[48, 49]. Deubiquitinating enzyme FAF-Y may function as a polyubiquitin hydrolase that counteracts the 348 
activity of TRIM33, an E3 ubiquitin-protein ligase [43]. TRIM33 is essential for activation of the NLRP3 349 
inflammasome [44]. FGFR1 has been shown to affect myofibroblast differentiation by inhibiting signaling by 350 
TGF-β1 and the FGF-1 ligand, events that lead to reversion of the EMT [45]. In terms of inflammation and 351 
fibrosis, IC formation would result in activation of the complement system, a process that is known to be 352 
involved in the pathogenesis of endometriosis [51]. 353 
 354 
6. Conclusions 355 
We comprehensively identified the constituent antigens of ICs in SP and FF via immune complexome 356 
analysis. Among the 391 and 327 human antigens detected in SP and FF, nine and eight antigens were found 357 
to be specific to subjects with spermatogenic dysfunction (four antigens for oligozoospemia and five antigens 358 
for asthenozoospermia) and ovarian endometriosis, respectively. Several antigens and the corresponding 359 
proteins coincide with known disease characteristics and may be involved in the pathogenesis of male and 360 
female infertility. Other specific antigens that lack known functions but were detected in SP and FF may have 361 
unknown roles in infertility. Immune complexome analysis may be a useful technique for revealing disease 362 
pathogenesis and may contribute to the development of new treatment strategies for reproductive dysfunction. 363 
However, our results, which were derived from a relatively limited number of subjects in the present work, 364 
will need to be confirmed in large-scale studies. Additionally, the exact relationship between specific antigens 365 
and male and female infertility related to spermatogenesis and endometriosis will need to be examined. We 366 
expect that further analysis of these disease-specific antigens may provide a better understanding of the 367 
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pathogenesis of both conditions. 368 
 369 
Aknowledgement 370 
This research was supported in part by the Grants-in-Aid for Scientific Research (grant no. 18K09294 and 371 





[1] Q. Chen, T. Deng, D. Han, Testicular immunoregulation and spermatogenesis, Semin. Cell Dev. Biol.59 375 
(2016) 157-165. https://doi: 10.1016/j.semcdb.2016.01.019 376 
[2] T. Zhang, C. De Carolis, G.C.W. Man, C.C. Wang, The link between immunity, autoimmunity and 377 
endometriosis: a literature update, Autoimmun. Rev. 17 (2018) 945-955. https://doi: 378 
10.1016/j.autrev.2018.03.017. 379 
[3] H.C. Schuppe, A. Meinhardt, J.P. Allam, M. Bergmann, W. Weidner, G. Haidl, Chronic orchitis: a 380 
neglected cause of male infertility? Andrologia 40 (2008) 84-91. https://doi: 381 
10.1111/j.1439-0272.2008.00837.x 382 
[4] M. Fijak, A. Pilatz, M.P. Hedger, N. Nicolas, S. Bhushan, V. Michel, et al, Infectious, inflammatory and 383 
'autoimmune' male factor infertility: how do rodent models inform clinical practice? Hum. Reprod. Update 384 
24 (2018) 416-441. https://doi: 10.1093/humupd/dmy009. 385 
[5] G. Kaur, S. Vadala, J.M. Dufour, An overview of a Sertoli cell transplantation model to study testis 386 
morphogenesis and the role of the Sertoli cells in immune privilege, Environ. Epigenet. 3 (2017) dvx012. 387 
https://doi: 10.1093/eep/dvx012. 388 
[6] M.P. Hedger, Immune Privilege of the Testis: Meaning, Mechanisms, and Manifestations, in: 389 
Stein-Streilein (ed.), Infection, Immune Homeostasis and Immune Privilege, Birkhäuser Advances in 390 
Infectious Diseases. Springer, Basel, 2012, pp. 31-52. https://doi: 10.1007/978-3-0348-0445-5_2. 391 
[7] A. Brazdova, H. Senechal, G. Peltre, P. Poncet, Immune Aspects of Female Infertility, Int. J. Fertil. Steril. 392 
10 (2016) 1-10. 393 
[8] M. Camargo, P. Intasqui, R.P. Bertolla, Understanding the seminal plasma proteome and its role in male 394 
 
20 
fertility, Basic Clin. Androl. 28 (2018) 6. https://doi: 10.1186/s12610-018-0071-5. 395 
[9] A.P. Drabovich, P. Saraon, K. Jarvi, E.P. Diamandis, Seminal plasma as a diagnostic fluid for male 396 
reproductive system disorders, Nat. Rev. Urol. 11 (2014) 278-88. https://doi: 10.1038/nrurol.2014.74. 397 
[10] J.M. Bieniek, A.P. Drabovich, K.C. Lo, Seminal biomarkers for the evaluation of male infertility. Asian J. 398 
Androl. 18 (2016) 426-33. https://doi: 10.4103/1008-682X.175781. 399 
[11] I. Batruch, I. Lecker, D. Kagedan, C.R. Smith, B.J. Mullen, E. Grober, et al, Proteomic analysis of 400 
seminal plasma from normal volunteers and post-vasectomy patients identifies over 2000 proteins and 401 
candidate biomarkers of the urogenital system, J. Proteome Res. 10 (2011) 941-53. https://doi: 402 
10.1021/pr100745u. 403 
[12] N.L. Anderson, M. Polanski, R. Pieper, T. Gatlin, R.S. Tirumalai, T.P. Conrads, et al, The human plasma 404 
proteome: a nonredundant list developed by combination of four separate sources, Mol. Cell. Proteomics 3 405 
(2004) 311-26. 406 
[13] P. Intasqui, M. Camargo, M.P. Antoniassi, A.P. Cedenho, V.M. Carvalho, K.H.M. Cardozo, et al, 407 
Association between the seminal plasma proteome and sperm functional traits, Ferti.l Steril. 105 (2016) 408 
617-628. https://doi: 10.1016/j.fertnstert.2015.11.005. 409 
[14] Y.H. Lin, Y.H. Chen, H.Y. Chang, H.K. Au, C.R. Tzeng, Y.H. Huang, Chronic Niche Inflammation in 410 
Endometriosis-Associated Infertility: Current Understanding and Future Therapeutic Strategies, Int. J. Mol. 411 
Sci. 19 (2018) pii: E2385. https://doi: 10.3390/ijms19082385. 412 
[15] T. Tanbo, P. Fedorcsak, Endometriosis-associated infertility: aspects of pathophysiological mechanisms 413 
and treatment options, Acta Obstet. Gynecol. Scand. 96 (2017) 659-667. https://doi; 10.1111/aogs.13082 414 
[16] M. Kitajima, S. Defrère, M.M. Dolmans, S. Colette, J. Squifflet, A. Van Langendonckt, et al, 415 
 
21 
Endometriomas as a possible cause of reduced ovarian reserve in women with endometriosis, Fertil. Steril. 416 
96 (2011) 685-91. https://doi: 10.1016/j.fertnstert.2011.06.064. 417 
[17] M. Kitajima, M.M. Dolmans, O. Donnez, H. Masuzaki, M. Soares, J. Donnez, Enhanced follicular 418 
recruitment and atresia in cortex derived from ovaries with endometriomas, Fertil. Steril. 101 (2014) 419 
1031-7. https://doi: 10.1016/j.fertnstert.2013.12.049. 420 
[18] V.H. Eisenberg, M. Zolti, D. Soriano, Is there an association between autoimmunity and endometriosis? 421 
Autoimmun. Rev. 11 (2012) 806-14. https://doi: 10.1016/j.autrev.2012.01.005. 422 
[19] L.D.G.C. Riccio, P. Santulli, L. Marcellin, M.S. Abrão, F. Batteux, C. Chapron, Immunology of 423 
endometriosis, Best Pract. Res. Clin. Obstet. Gynaecol. 50 (2018) 39-49. https://doi: 424 
10.1016/j.bpobgyn.2018.01.010. 425 
[20] D. Caccavo, N.M. Pellegrino, I. Totaro, M.P. Vacca, L. Selvaggi, R. Depalo, Anti-laminin-1 antibodies in 426 
sera and follicular fluid of women with endometriosis undergoing in vitro fertilization, Int. J. 427 
Immunopathol. Pharmacol. 24 (2011) 481-8. https://doi: 10.1177/039463201102400221. 428 
[21] K. Haller-Kikkatalo, A. Salumets, R. Uibo, Review on autoimmune reactions in female infertility: 429 
antibodies to follicle stimulating hormone, Clin. Dev. Immunol. 2012 (2012) 762541. https://doi: 430 
10.1155/2012/762541. 431 
[22] Rodgers RJ, Irving-Rodgers HF. Formation of the ovarian follicular antrum and follicular fluid, Biol 432 
Reprod. 82 (2010) 1021-9. https://doi: 10.1095/biolreprod.109.082941. 433 
[23] G. Wu, N.A. Bersinger, M.D. Mueller, M. von Wolff, Intrafollicular inflammatory cytokines but not 434 
steroid hormone concentrations are increased in naturally matured follicles of women with proven 435 
endometriosis, J. Assist. Reprod. Genet. 34 (2017) 357-364. https://doi: 10.1007/s10815-016-0865-3. 436 
 
22 
[24] M.O. Bahtiyar, E. Seli, E. Oral, L.M. Senturk, T.G. Zreik, A. Arici, Follicular fluid of women with 437 
endometriosis stimulates the proliferation of endometrial stromal cells, Hum. Reprod. 13 (1998) 3492-5. 438 
[25] R. Nezlin, A Quantitative Approach to the Determination of Antigen in Immune Complexes, J. Immunol. 439 
Methods 237 (2000) 1–17. 440 
[26] A.K. Chauhan, Editorial: Immune Complexes in Disease Pathology. Front Immunol. 8 (2017) 173. 441 
https://doi: 10.3389/fimmu.2017.00173. 442 
[27] K. Ohyama, Y. Ueki, A. Kawakami, N. Kishikawa, M. Tamai, M. Osaki, et al, Immune complexome 443 
analysis of serum and its application in screening for immune complex antigens in rheumatoid arthritis, 444 
Clin Chem 57 (2011) 905-9. https://doi: 10.1373/clinchem.2010.157776. 445 
[28] N. Aibara, K. Ichinose, M. Baba, H. Nakajima, K. Satoh, R. Atarashi, et al, Proteomic approach to 446 
profiling immune complex antigens in cerebrospinal fluid samples from patients with central nervous 447 
system autoimmune diseases, Clin. Chim. Acta 484 (2018) 26-31. https://doi: 10.1016/j.cca.2018.05.026. 448 
[29] K. Ohyama, N.T. Huy, H. Yoshimi, N. Kishikawa, J.E. Nishizawa, Y. Roca, et al, Proteomic Profile of 449 
Circulating Immune Complexes in Chronic Chagas Disease, Parasite Immunol. 38 (2016) 609-17. 450 
https://doi: 10.1111/pim.12341. 451 
[30] K. Ohyama, H. Yoshimi, N. Aibara, Y. Nakamura, Y. Miyata, H. Sakai, et al, Immune Complexome 452 
Analysis Reveals the Specific and Frequent Presence of Immune Complex Antigens in Lung Cancer 453 
Patients: A Pilot Study, Int. J. Cancer 140 (2017) 370-380. https://doi: 10.1002/ijc.30455. 454 
[31] N. Aibara, K. Ohyama, M. Hidaka, N. Kishikawa, Y. Miyata, M. Takatsuki, et al, Immune complexome 455 
analysis of antigens in circulating immune complexes from patients with acute cellular rejection after 456 




[32] World Health Organization. WHO laboratory manual for the examination and processing of human 459 
semen. 5th ed. Geneva: World Health Organization; 2010. 460 
[33] N. Aibara, C. Kamohara, A.K. Chauhan, N. Kishikawa, Y. Miyata, M. Nakashima, et al, Selective, 461 
sensitive and comprehensive detection of immune complex antigens by immune complexome analysis with 462 
papain-digestion and elution, J. Immunol. Methods 461 (2018) 85-90. https://doi: 463 
10.1016/j.jim.2018.06.021. 464 
[34] American Society for Reproductive Medicine. Revised American Society for Reproductive Medicine 465 
classification of endometriosis: 1996. Fertil Steril 1997;67:817-21. 466 
[35] S.E. Ritzmann, J.C. Daniels, Immune complexes: characteristics, clinical correlations, and interpretive 467 
approaches in the clinical laboratory, Clin. Chem. 28 (1982) 1259-71. 468 
[36] M. Itoh, Testicular Autoimmunity. A cause of male infertility, Springer, Tokyo, 2017, pp. 1-232. 469 
https://doi; 10.1007/978-4-431-54460-9. 470 
[37] N.P. Lee, D.D. Mruk, A.M. Conway, C.Y. Cheng, Zyxin, axin, and Wiskott-Aldrich syndrome protein are 471 
adaptors that link the cadherin/catenin protein complex to the cytoskeleton at adherens junctions in the 472 
seminiferous epithelium of the rat testis, J. Androl. 25 (2004) 200-15. 473 
[38] J. Toshima, J.Y. Toshima, K. Takeuchi, R. Mori, K. Mizuno, Cofilin phosphorylation and actin 474 
reorganization activities of testicular protein kinase 2 and its predominant expression in testicular Sertoli 475 
cells, J. Biol. Chem. 276 (2001) 31449-58. https://doi: 10.1074/jbc.M102988200. 476 
[39] P.F. Oliveira, C.Y. Cheng, M.G. Alves, Emerging Role for Mammalian Target of Rapamycin in Male 477 
Fertility, Trends Endocrinol. Metab. 28 (2017) 165-167. https://doi: 10.1016/j.tem.2016.12.004. 478 
 
24 
[40] K. Shimada, I. Filipuzzi, M. Stahl, S.B. Helliwell, C Studer, D. Hoepfner, et al, TORC2 signaling 479 
pathway guarantees genome stability in the face of DNA strand breaks. Mol. Cell 51 (2013) 829-39. 480 
https://doi: 10.1016/j.molcel.2013.08.019. 481 
[41] X.M. Wang, Z. Xiang, Y. Fu, H.L. Wu, W.B. Zhu, L.Q. Fan, Comparative Proteomics Reveal the 482 
Association between SPANX Proteins and Clinical Outcomes of Artificial Insemination with Donor Sperm, 483 
Sci. Rep. 8 (2018) 6850. https://doi: 10.1038/s41598-018-25032-4. 484 
[42] S. Rose-John, IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory 485 
activities of IL-6, Int. J. Biol. Sci. 8 (2012) 1237-47. https://doi: 10.7150/ijbs.4989. 486 
[43] S. Dupont, A. Mamidi, M. Cordenonsi, M. Montagner, L. Zacchigna, M. Adorno, et. Al, FAM/USP9x, a 487 
deubiquitinating enzyme essential for TGFbeta signaling, controls Smad4 monoubiquitination. Cell 136 488 
(2009) 123-35. https://doi: 10.1016/j.cell.2008.10.051. 489 
[44] L. Weng, H. Mitoma, C. Trichot, M. Bao, Y. Liu, Z. Zhang, et al, The E3 ubiquitin ligase TRIM33 is 490 
essential for cytosolic RNAinduced NLRP3 inflammasome activation, J. Immunol. 193 (2014) 3676–3682. 491 
https://doi: 10.4049/jimmunol.1401448. 492 
[45] C. Shimbori, P.S. Bellaye, J. Xia, J Gauldie, K. Ask, C. Ramos, et al, Fibroblast growth factor-1 493 
attenuates TGF-β1-induced lung fibrosis, J. Pathol. 240 (2016) 197-210. https://doi: 10.1002/path.4768 494 
[46] T. Iwabe, T. Harada, N. Terakawa, Role of cytokines in endometriosis-associated infertility, Gynecol. 495 
Obstet. Invest. 53 (2002) 19-25. 496 
[47] F. Schaper, S. Rose-John, Interleukin-6: Biology, signaling and strategies of blockade, Cytokine Growth 497 
Factor Rev. 26 (2015) 475-87. https://doi: 10.1016/j.cytogfr.2015.07.004. 498 
[48] M.N. Patel, R.G. Carroll, S. Galván-Peña, E.L. Mills, R. Olden, M. Triantafilou, et al, Inflammasome 499 
 
25 
Priming in Sterile Inflammatory Disease, Trends Mol. Med. 23 (2017) 165-180. https://doi: 500 
10.1016/j.molmed.2016.12.007. 501 
[49] Y.M. Yang, W.X. Yang, Epithelial-to-mesenchymal transition in the development of endometriosis, 502 
Oncotarget 8 (2017) 41679-41689. https://doi: 10.18632/oncotarget.16472. 503 
[50] Y. Song, J. Liu, Z. Qiu, D. Chen, C. Luo, X. Liu, et al, Advanced oxidation protein products from the 504 
follicular microenvironment and their role in infertile women with endometriosis, Exp. Ther. Med. 15 505 
(2018) 479-486. https://doi: 10.3892/etm.2017.5390. 506 
[51] S. Suryawanshi, X. Huang, E. Elishaev, R.A. Budiu, L. Zhang, S. Kim, et al, Complement pathway is 507 
frequently altered in endometriosis and endometriosis-associated ovarian cancer, Clin. Cancer Res. 20 508 




Results of semen analysis 
Oligozoospermia (n=6) Asthenozoospermia (n=8) Normal (n=28) 
Age (years) 41 ±6 39 ±3 38 ±6 





 85 ±48 104 ±47 




 58 ±13 
 
Footnote: Data are presented as mean SD (standard deviation). Age, semen volume, sperm concentration, and motility were compared among the three groups. After an F test was 
used to check the variance among the groups, age, semen volume, and motility were analyzed using a two-tailed Kruskal-Wallis H test with a post-hoc Dunnett’s test, while sperm 
concentration was analyzed using a two-tailed one-way Analysis of Variance (ANOVA) with a post-hoc Tukey-Kramer test. 
a  p < 0.001 versus normal semen. 






Clinical background of female subjects who provided follicular fluid 
Endometriosis (n=10) Control (n=48) 
Age (years) 36 ±4 37 ±4 
Serum AMH (ng/mL) 2.4 ±1.6 3.1 ±2.7 
Number of retrieved oocytes 6 ±7 8 ±7 
Nulligravida 7 (70%) 27 (56%) 
Nullipara 10 ( 100%) 40 (83%) 
Stage of endometriosis 
III 5 (50%) - 
IV 5 (50%) - 
Follicular fluid collected from ovary with endometriomas 6 (60%) - 
Recurrent cyst at OPU  5 (50%) - 
 
Foot note: Age, serum AMH (anti-Müllerian hormone), and the number of retrieved oocytes are presented as mean SD (standard deviation). To compare between groups, a 
Mann-Whitney U test was used to analyze age, serum AMH, and the number of retrieved oocytes; a Fisher’s exact test was used to analyze gravidity and parity. There were no 
statistically significant differences between the two groups for any of these variables. 
All women in the Endometriosis group has been diagnosed histologically as having uni- or bilateral endometriotic cyst(s). 






Specific antigens found only in the oligozoospermia group 
Accession Q9BXN6 Q15942 Q9UHY8 Q96I59 
Description 
Sperm protein associated with the nucleus 
on the X chromosome D 
(SPANX-D) 
Zyxin 





1 ● ● ● 
2 ● ● ● 




Frequency (%)a 50 33.3 33.3 33.3 
Footnote: Four specific antigens were found in four of six subjects in the oligozoospermia group. 
a Frequency (%) of each antigen was calculated based on the number of oligozoospermia subjects (n=6).  
The table shows how many antigens were detected in each patient. No specific antigens were found in cases No. 5 and No. 6. 
●: Presence of specific antigen 
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Table 4  
Specific antigens found only in the asthenozoospermia group 
Accession Q96S53 Q15751 Q2LD37 Q9NVM4 Q8NE71 
Description 
Dual specificity testis-specific 










sub-family F member 1  
Case 
1 ● ● ● 









 25 25 25 25 25 
Footnote: Five specific antigens were found in six of eight subjects in the asthenozoospermia group. 
aFrequency (%) of each antigen was calculated based on the number of asthenozoospermia subjects (n=8).   
The table shows how many antigens were detected in each patient. No specific antigens were found in cases No. 7 and No. 8. 




Specific antigens found only in patients with endometriosis 


























1 ● ● ● ● ● 
2 ● ● ● ● 
3 ● ● ● 









 20 20 20 20 20 20 20 20 
Footnote: Eight specific antigens were found in six of ten subjects in the endometriosis group. 
aFrequency (%) of each antigen was calculated based on the number of subjects with endometriosis (n=10).  
The table shows how many antigens were detected in each patient. No specific antigens were found in cases No. 7 to No. 10. 
●: Presence of specific antigen 
